1Chang H,Kuo M C,Shih L Y. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia[J].European Journal of Haematology,2012,(04):321-328.doi:10.1111/j.1600-0609.2011.01747.x.
2Mi J Q,Li J M,Shen Z X. How we treat acute promyelocytic leukemia[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2012.
3Frankel S R,Eardley A,Lauwers G. The "retinoic acid syndrome" in acute promyelocytic leukemia[J].Annals of Internal Medicine,1992,(04):292-296.
4Asou N,Adachi K,Tamura J. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.Japan Adult Leukemia Study Group[J].Journal of Clinical Oncology,1998,(01):78-85.
5Frankel S R,Eardley A,Heller G. All-trans retinoic acid for acute promyelocytic leukemia.Results of the New York Study[J].Annals of Internal Medicine,1994,(04):278-286.
6Tallman M S,Andersen J W,Schiffer C A. All-trans-retinoic acid in acute promyelocytic leukemia[J].New England Journal of Medicine,1997,(15):1021-1028.doi:10.1056/NEJM199710093371501.
7de la Serna J,Montesinos P,Vellenga E. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin[J].Blood,2008,(07):3395-3402.
8Soignet S L,Frankel S R,Douer D. United States multicenter study of arsenic trioxide in relapsed acute promyelocyticleukemia[J].Journal of Clinical Oncology,2001,(18):3852-3860.
9Sethna C B,Reddy K,Fein Levy C. Nephrotic-range proteinuria in a child with retinoic acid syndrome[J].Pediatric Nephrology,2012,(03):485-488.doi:10.1007/s00467-011-2048-x.
10Choi S,Kim H S,Jung C S. Reversible symptomatic myocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia:rare cardiac manifestation as a retinoic acid syndrome[J].J Cardiovasc Ultrasound,2011,(02):95-98.
1ZHOU Jin1,MENG Ran1,2,SUI Xinhua2,LI Wenbin3 & YANG Baofeng1 1.The First Hospital of Harbin Medical University,Harbin 150001,China,2. Shijitan Hospital,The Ninth Clinical Medical College of Peking University,Beijing 100038,China,3. Xuanwu Hospital,Capital University of Medical Sciences,Beijing 100053,China.Various tolerances to arsenic trioxide between human cortical neurons and leukemic cells[J].Science China(Life Sciences),2006,49(6):567-572. 被引量：6
3Aribi A,Kantarjian H M,Estey E H,et al.Combination therapy arsenic trioxide,all- trans retinic acid and gemtuzumabozoganlicin in recurrent acute promyelocytic leukemia[J] .Cancer,2007; 109(7): 1355-1350.
4Xin L,Wan Jun S,Zeng Jun L,et al.A survival study prognostic factor analysis on acute promyelocytic leukemia at a single center[J].Leuk Rcs,2007;31(6):765-771.
